
Dubace Tablet
Marketer
Mapra Laboratories Pvt Ltd
Salt Composition
Tranexamic Acid (500mg) + Mefenamic Acid (250mg)
Overview Dubace Tablet
Femstop combines medications to alleviate heavy menstrual bleeding and associated discomfort. It works by stabilizing blood clots, thus reducing excessive menstrual flow, and suppressing pain-inducing and inflammatory chemical signals. Femstop can be ingested with food at any time, but consistent daily timing is recommended, ideally commencing on the first day of menstruation for optimal efficacy. Continue the prescribed regimen until your physician advises otherwise. Missed doses should be taken immediately upon recollection. Complete the full course, even with symptom improvement. Report any lack of menstrual changes after three consecutive cycles. Common side effects include nausea, abdominal pain, headache, nasal stuffiness, sinus pain/inflammation, skin rash, fatigue, and musculoskeletal discomfort. Diarrhea is also possible; increased fluid intake is recommended to prevent dehydration. Consult your doctor if menstrual changes are absent after three cycles. Prior to use, disclose any kidney issues, vaginal bleeding disorders, pregnancy, breastfeeding, or other concurrent medications. Regular eye examinations may be necessary during treatment. Alcohol consumption should be avoided.
Uses of Dubace Tablet
Managing Excessive Menstrual Flow | Alleviating Menstrual Cramps
Major Benefits of Dubace Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment duration for Dubace Tablet. Ingest the tablet whole; do not crush, chew, or divide it. Administer Dubace Tablet with a meal.
Common Side effects of Dubace Tablet:
- Nausea
- Vomiting
- Heartburn
- Indigestion
- Diarrhea
- Loss of appetite
- Nasal congestion (stuffy nose)
- Headache
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
- Stomach pain
- Sinus pain
- Sinus inflammation
How to use Dubace Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dubace Tablet with a meal.
How Dubace Tablet works:
Dubace Tablet combines Tranexamic Acid, an antifibrinolytic that stabilizes blood clots to reduce menstrual bleeding, with Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID). Mefenamic Acid alleviates pain and inflammation by inhibiting the formation of prostaglandins, inflammatory chemical mediators.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Dubace Tablet is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Dubace Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of Dubace Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Dubace Tablet may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Dubace Tablet, potentially requiring dosage modification. A physician's consultation is advised. Dubace Tablet is contraindicated for individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
Use of Dubace Tablet in patients with liver impairment is likely safe. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Dubace Tablet :
Should you forget to take your Dubace Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dubace Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
